These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9142213

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK, Weksberg R, Minden MD, Squire JA.
    Biochem Biophys Res Commun; 1997 Feb 13; 231(2):466-72. PubMed ID: 9070302
    [Abstract] [Full Text] [Related]

  • 24. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y, Meng G, Huang L, Guo QN.
    Hum Pathol; 2009 Oct 13; 40(10):1441-7. PubMed ID: 19427670
    [Abstract] [Full Text] [Related]

  • 25. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K, Fukumoto M, Jinno Y.
    Am J Pathol; 1996 Apr 13; 148(4):1081-7. PubMed ID: 8644850
    [Abstract] [Full Text] [Related]

  • 26. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK, Squire JA, Catzavelos CG, Weksberg R.
    Biochem Biophys Res Commun; 1997 Jun 09; 235(1):123-9. PubMed ID: 9196048
    [Abstract] [Full Text] [Related]

  • 27. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver.
    Aihara T, Noguchi S, Miyoshi Y, Nakano H, Sasaki Y, Nakamura Y, Monden M, Imaoka S.
    Hepatology; 1998 Jul 09; 28(1):86-9. PubMed ID: 9657100
    [Abstract] [Full Text] [Related]

  • 28. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H.
    Gynecol Oncol; 2006 Dec 09; 103(3):990-5. PubMed ID: 16859738
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M, Okuyama A.
    Cancer Res; 1997 Jul 01; 57(13):2575-7. PubMed ID: 9205056
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
    Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P.
    Cancer Res; 2004 Sep 01; 64(17):6058-64. PubMed ID: 15342387
    [Abstract] [Full Text] [Related]

  • 34. [Expression of gene products of insulin-like-growth-factor II, insulin-like-growth-factor II receptor and colony-stimulating-factor-I receptor in human primary hepatocellular carcinoma and non-cancerous liver tissues].
    Yang D.
    Zhonghua Yi Xue Za Zhi; 1992 Aug 01; 72(8):476-80, 510. PubMed ID: 1337723
    [Abstract] [Full Text] [Related]

  • 35. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI.
    Oncogene; 2000 Aug 03; 19(33):3717-26. PubMed ID: 10949925
    [Abstract] [Full Text] [Related]

  • 36. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.
    Tang SH, Yang DH, Huang W, Zhou M, Zhou HK, Lu XH, Ye G.
    Cancer Detect Prev; 2006 Aug 03; 30(2):192-203. PubMed ID: 16697535
    [Abstract] [Full Text] [Related]

  • 37. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK, Yang DH, Tang SH, Huang W, Lu XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):106-10. PubMed ID: 16620715
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
    Haddad R, Held WA.
    Cancer Res; 1997 Oct 15; 57(20):4615-23. PubMed ID: 9377577
    [Abstract] [Full Text] [Related]

  • 40. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
    Yao JC, Hu YL, Wang ZQ, Dai YM, Ling JX, Ye XD.
    Zhonghua Fu Chan Ke Za Zhi; 2007 May 15; 42(5):309-14. PubMed ID: 17673042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.